Search

everythinglearnresearchcommunity

for

Search:↓

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Skin issues can indicate immune system problems.

Amphetamine use may not cause hair loss, "geezer" traits are normal aging, not all educated older people are stereotypes, and metronidazole can rarely cause lung disease.

Amphetamines may not directly cause hair loss.

Reassurance is important for postpartum hair shedding as it likely won't cause complete baldness.

Monocytes might be linked to hair loss after COVID-19.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Nivolumab can cause hair loss as a rare side effect.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

Imatinib can cause hair loss due to lichen planopilaris.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

COVID-19 infection can significantly cause temporary hair loss.

Topical Valproate is safe for human skin and unlikely to cause irritation.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

A child's hair loss after Kawasaki disease may help understand the disease's autoimmune causes.

Kawasaki's disease can occur in adults and should be considered with specific symptoms and high ferritin levels.

Nilotinib can cause generalized keratosis pilaris.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

The woman was diagnosed with systemic lupus erythematosus (SLE) after initial misdiagnosis and improved with proper treatment.

Polynucleotide gel injections help reduce hair loss and increase hair thickness in people with pattern hair loss, with few side effects.